郑州近视眼手术需多少钱郑州在郑州近视手术费,郑州300度最便宜的近视镜多少钱?,郑州如果当兵体检眼睛近视怎么办,郑州小儿斜视治疗方法,郑州治疗斜视大概多少钱,郑州儿童视力,郑州郑州做近视手术哪个医院好

The RV industry, like every other sector of the travel industry, took a hit in business at the start of the coronavirus pandemic.“April was down about 30 to 35%,” said Jim Bracking.Bracking is the manager of the Loveland RV Resort in Colorado.“For every reservation we were gettingm we were getting a couple of cancellations,” Bracking added.However, about a month after a slew of cancellations came in, things have started to pick up significantly.“Reservations are up quite a bit,” said Bracking. “If you have been in the office, you could see the reservation clerks are very busy.”Vacationers started rebooking road trips as soon as Colorado and other states started to reopen.“You just got to get some form of normalcy back and yet be safe. This is one of the only ways we know how to do it,” said Suzie Limppo, who is vacationing in an RV at Loveland RV Resort.RV resorts, RV parks, and RV rentals are seeing a bounce back across the country.“We are now up over 1,000 percent from where we were in April,” said Jon Gray with RVshare.RVshare rents RV to vacationers and it’s just one RV rental company that has seen dramatic increases in rentals.“There is a premium on keeping your distance. There’s a premium on driving to where you want to go instead of flying, because people are afraid to get on airplanes right now,” said Gray. “So, we thought those things benefitted our business, but we didn’t realize it benefitted it as much as it has. It has been truly amazing.”The RV industry is one of the only sectors of travel and leisure seeing such a strong rebound, and until the threat of COVID-19 is behind us, industry experts expect continued high demand.“It is clear that this summer is a moment for the RV industry, for drive-to travel and for people kind of experiencing travel in a different way,” said Gray.Because of high demand, RV rental companies and resorts warn those interested in taking road trips and camping should book soon.“If somebody want to go camping, they should book their reservations now,” said Bracking. “For this year and even next year, because they are filing up and I suspect by July 4 they are going to be very full.” 2165

The United States State Department has lifted a worldwide Level 4 travel advisory which had been in place since the spring amid the spread of the coronavirus.A Level 4 advisory is the highest alert level at the State Department, which warns travelers of life-threatening risks.The State Department still has a number of Level 4 advisories across the globe, including neighboring Mexico.The change in status, however, might not have much impact on travelers as many countries have placed strict limits on non-essential travel from the United States. And with the United States still leading the world in coronavirus cases and deaths, Americans ability to travel internationally is expected to be limited for months to come. 730

The school shooting was over in seconds. But it could have dragged on longer and proven deadlier were it not for the rapid response of a school resource officer.When a 17-year-old gunman walked into Maryland's Great Mills High School on Tuesday, the swift action of the school's sole resource officer, Blaine Gaskill, was instrumental in bringing the incident to a quick end.Gaskill's response was hailed as an example of exactly what a resource officer is supposed to do in such a circumstance, particularly when contrasted to the actions of the security officer in last month's shooting in Parkland, Florida. (In the incident at Marjory Stoneman Douglas High School on February 14, the armed school resource deputy waited outside the school building as the shooter gunned down students inside.)"He responded exactly how we train our personnel to respond," St. Mary's County Sheriff Tim Cameron told reporters.Engaging the shooterAs soon as the gunfire began, Gaskill rushed to the scene. He fired a round at the shooter, who also fired a round at the same time, Cameron said.It's not yet clear whether the shooter, Austin Wyatt Rollins, was felled by the officer's bullet or killed himself."DFC [Deputy First Class] Gaskill fired at the shooter ... almost simultaneously as the shooter fired," Cameron said. "This is something we train, practice and in reality, hope would never come to fruition. This is our worst nightmare."Gov. Larry Hogan called Gaskill "a very capable school resource officer who also happened to be a SWAT team member.""This is a tough guy who apparently closed in very quickly and took the right kind of action," he said. "And while I think it's still tragic, he may have saved other people's lives."Over in secondsThe incident began in a school hallway at 7:55 a.m., just before classes started. Authorities say Austin, armed with a handgun, shot a female student, with whom he had a prior relationship, and another male student.Gaskill responded to the scene in less than a minute, the sheriff said.Cameron said the entire incident took less than a minute, possibly seconds.The 16-year-old female student is in critical condition with life-threatening injuries, and the 14-year-old male student who was shot is in stable condition.Gaskill was unharmed."He's doing well and we're going to do everything to support and promote him and his well-being," Cameron said.Playing to a narrativeGaskill's actions were praised, rightly, across social media. But some -- most notably, the NRA -- held him up as an example of the "good guy with a gun" theory. The theory goes, that bad guys will always find a way to circumvent whatever gun laws are in place. And "to stop a bad guy with a gun," as NRA head Wayne Lapierre?said, "it takes a good guy with a gun.""This [Great Mills High School] armed school resource officer, you're not hearing anyone in #MSM talk about it because it disrupts their narrative," NRA spokeswoman Dana Loesch said in one of several tweets Tuesday. (MSM is short for mainstream media.)So far, this year, there have already been 17 school shootings where someone was hurt or killed.In the Parkland shooting, school resource deputy Scot Peterson never entered the building after taking a position outside. He resigned after he was suspended without pay for his inaction."Had our resource officer taken action immediately, the result of the Stoneman Douglas Valentine's Day Massacre would have been different," Parkland student Kai Koerber told CNN."We might not have had to walk over the bodies of our classmates, once lovely and wonderful people, as we were led away from murderous tragedy."Speaking to reporters, Dr. James Scott Smith, the superintendent of St. Mary's County's public schools, put the senselessness of it all in perspective."It looks as though the SRO [school resource officer] did exactly what the SRO is trained to do, and yet we still have a tragic loss of life," he said. "We still have somebody in critical condition. And we have students at the school and staff at the school impacted." 4086

The U.S. regulators who will decide the fate of COVID-19 vaccines are taking an unusual step: Asking outside scientists if their standards are high enough.The Food and Drug Administration may have to decide by year’s end whether to allow use of the first vaccines against the virus. Thursday, a federal advisory committee pulls back the curtain on that decision process, debating whether the guidelines FDA has set for vaccine developers are rigorous enough.“We will not cut corners, and we will only use science and data to make that determination,” FDA Commissioner Stephen Hahn pledged at a meeting of the Milken Institute Wednesday.Exactly how much data his agency needs to be sure a vaccine is safe and effective is a key question for the advisers. An even bigger one: If the FDA allows emergency use of a vaccine before final testing is finished, will that destroy chances of ever learning just how well that shot -- and maybe competitors still being studied -- really work?“We can’t lose sight of the fact that it is in our societal interest to see these trials to completion,” said Dr. Luciana Borio, a former FDA acting chief scientist who will be watching the advisers’ debate.Plus, multiple vaccines are being studied -- shots made with different technologies that each have pros and cons.“The first vaccine is not necessarily the best vaccine,” cautioned Dr. M. Miles Braun, a former FDA scientist now with Georgetown University School of Medicine. If the trials aren’t allowed to finish, it may be difficult or impossible to ever know for sure.It’s a critical moment in FDA’s 114-year history. The government has spent billions to race a vaccine through a research process that usually takes years, and FDA faces unprecedented pressure from the Trump administration, fueling public skepticism that politics could overrule science.Interest is so high, FDA is airing the meeting on YouTube. Here are some key issues the committee will discuss:HOW MUCH EVIDENCE IS NEEDED?FDA is requiring manufacturers to do studies of at least 30,000 people to prove if a vaccine protects and how safe it is. Those studies must include adequate numbers of people at highest risk from COVID-19 -- older adults, minorities and anyone with underlying health problems.FDA has made clear that any vaccine must be at least 50% effective. And while the studies are designed to run for two years, companies may get enough evidence the shots are protective -- in at least some people -- to stop the trials early and seek what’s called an “emergency use authorization” for wider vaccinations.Despite White House objections, the FDA told vaccine makers earlier this month not to seek that speedier review until they’ve tracked at least half their trial participants for two months. With other vaccines, that’s about the amount of time when major side effects crop up.That’s not long enough, said the head of the non-profit ECRI Institute, which reviews medical technology for hospitals and insurers. In comments submitted to the advisory committee, ECRI’s Dr. Marcus Schabacker said FDA should require six months of follow-up.“Doing any less would simply risk too much, and the consequences may be severe,” he wrote. “A weak vaccine that loses public trust could poison the well for epidemic control for many years.”WOULD EMERGENCY USE DERAIL FULL ANSWERS ABOUT VACCINES?Normally when a study ends because of evidence that a vaccine is working, the participants who got dummy shots are offered the real thing.But if FDA allows emergency use of a COVID-19 vaccine, that’s not the same as having full proof the shot works, Borio cautioned.And if the participants in the placebo group are immediately offered the real shot, researchers may not be able to get answers about all the high-risk groups in the study — or tell how long the vaccine’s protection lasts, a process expected to take many more months.But Pfizer Inc., which with Germany’s BioNTech is developing one of the leading candidates, told FDA that if it’s granted emergency use authorization, it “would have an ethical obligation” to alert study participants who got a placebo and allow them vaccine access. The company wants FDA to look into “other scientifically and statistically sound methods” to determine long-term safety and effectiveness.Pfizer’s stance is likely to face pushback. The Infectious Diseases Society of America states that FDA’s panelists “should insist” that vaccine developers “present a compelling case” for how they will complete their trials if FDA grants early authorization of their vaccine.Clearing a vaccine based on premature or faulty data “could cause more harm” by “further eroding public confidence in all vaccines,” the group said.It’s an unprecedented dilemma. The FDA has previously allowed emergency use of only one vaccine, a decades-old shot that in 2005 was authorized to prevent anthrax poisoning.This time around, multiple COVID-19 vaccines are in the pipeline. Pfizer competitor Johnson & Johnson cautioned that early FDA clearance of one vaccine could “jeopardize integrity” of other ongoing trials if patients decide to drop out to seek the first cleared shot instead.The company asked regulators to explain what options are available to ensure completion of all ongoing COVID-19 vaccine trials.WHAT ABOUT LONG-TERM SAFETY MONITORING?Even a study of 30,000 people cannot spot a side effect that only strikes 1 in 100,000. So the government is planning extra scrutiny of every COVID-19 vaccine to hit the market.At first there will be limited doses given to just certain high-risk people -- and those early recipients are to get text messages daily for the first week after vaccination, and then weekly out to six weeks, asking how they’re feeling.FDA also will be checking databases of electronic health records and insurance claims, looking for any red flags.“There’s a kind of tracking that has to take place here on a massive basis that hasn’t taken place before,” said Dr. Jesse Goodman of Georgetown University, a former director of the FDA’s vaccine and biologics center.___The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content. 6274

The US Centers for Disease Control and Prevention warned US consumers on Tuesday to not eat romaine lettuce, as it may be contaminated with E. coli.Thirty-two people, including 13 who have been hospitalized, have been infected with the outbreak strain in 11 states, according to the CDC. One of the hospitalized people developed hemolytic uremic syndrome, a potentially life-threatening form of kidney failure. No deaths have been reported.People have become sick in California, Connecticut, Illinois, Massachusetts, Maryland, Michigan, New Hampshire, New Jersey, New York, Ohio and Wisconsin.The Public Health Agency of Canada has identified an additional 18 people who have become sick with the same strain of of E. coli in Ontario and Quebec.If you have any romaine lettuce at home, you should throw it away, even if you have eaten some and did not get sick, the CDC cautioned."This advice includes all types or uses of romaine lettuce, such as whole heads of romaine, hearts of romaine, and bags and boxes of precut lettuce and salad mixes that contain romaine, including baby romaine, spring mix, and Caesar salad," the CDC said in its announcement.All types and brands of romaine lettuce are suspect because no common grower, supplier, distributor or source company has been identified by the CDC.Retailers and restaurants also should not serve or sell any until more is known about the outbreak.Symptoms of E. coli infection, which usually begin about three or four days after consuming the bacteria, can include watery or bloody diarrhea, fever, abdominal cramps, nausea and vomiting, according to the CDC. Most people infected by the bacteria get better within five to seven days, though this particular strain of E. coli tends to cause more severe illness.People of all ages are at risk of becoming infected with Shiga toxin-producing E. coli, according to the US Food and Drug Administration, which is also investigating the outbreak. Children under 5, adults older than 65 and people with weakened immune systems, such as people with chronic diseases, are more likely to develop severe illness, but even healthy children and adults can become seriously ill.Illnesses started in October. This outbreak is not related to a multistate outbreak linked to romaine lettuce this summer.The-CNN-Wire 2311